Transgenic expression of human CD47 reduces phagocytosis of porcine endothelial cells and podocytes by baboon and human macrophages.


Journal

Xenotransplantation
ISSN: 1399-3089
Titre abrégé: Xenotransplantation
Pays: Denmark
ID NLM: 9438793

Informations de publication

Date de publication:
01 2020
Historique:
received: 25 03 2019
revised: 12 06 2019
accepted: 24 07 2019
pubmed: 10 9 2019
medline: 21 5 2021
entrez: 10 9 2019
Statut: ppublish

Résumé

Our initial studies utilizing a galactosyl-α1-3-galactosyltransferase gene knockout (GalTKO) pig-to-baboon renal transplant model demonstrated that the early development of nephrotic syndrome has been a significant obstacle to the long-term survival of baboon recipients. We have recently documented that sphingomyelin phosphodiesterase-3 (SMPDL3b) and CD80 expressed on podocytes in porcine kidney grafts contribute to this complication. We have hypothesized that one regulator of immune function is CD47 and that incompatibilities in CD47 between pig and baboon could potentially affect macrophage function, increasing the susceptibility of the kidney grafts to immunologically induced injury. In order to address this hypothesis in vitro, we isolated and cultured porcine podocytes and ECs from GalTKO alone, human CD47 (hCD47)/hCD55 expressing transgenic (Tg) GalTKO swine, and GalTKO hCD46/hCD55 Tg swine along with baboon or human macrophages. We found that baboon macrophages phagocytosed porcine ECs in a similar manner to human macrophages, and this response was significantly reduced when porcine ECs and podocytes expressed hCD47/hCD55 but not hCD46/hCD55 without hCD47. Furthermore, masking hCD47 by anti-hCD47 antibody on hCD47/hCD55Tg ECs restored phagocytosis. These results are consistent with the hypothesis that CD47 incompatibility plays an important role in promoting macrophage phagocytosis of endogenous cells from the transplanted kidney. The similar levels of phagocytosis of porcine cells by baboon and human macrophages suggest that the expression of hCD47Tg on glomerular cells in donor porcine kidneys may prove to be a key strategy for preventing proteinuria following kidney xenotransplantation in a pig-to-human as well as a pig-to-baboon model.

Sections du résumé

BACKGROUND
Our initial studies utilizing a galactosyl-α1-3-galactosyltransferase gene knockout (GalTKO) pig-to-baboon renal transplant model demonstrated that the early development of nephrotic syndrome has been a significant obstacle to the long-term survival of baboon recipients. We have recently documented that sphingomyelin phosphodiesterase-3 (SMPDL3b) and CD80 expressed on podocytes in porcine kidney grafts contribute to this complication. We have hypothesized that one regulator of immune function is CD47 and that incompatibilities in CD47 between pig and baboon could potentially affect macrophage function, increasing the susceptibility of the kidney grafts to immunologically induced injury.
METHODS
In order to address this hypothesis in vitro, we isolated and cultured porcine podocytes and ECs from GalTKO alone, human CD47 (hCD47)/hCD55 expressing transgenic (Tg) GalTKO swine, and GalTKO hCD46/hCD55 Tg swine along with baboon or human macrophages.
RESULTS
We found that baboon macrophages phagocytosed porcine ECs in a similar manner to human macrophages, and this response was significantly reduced when porcine ECs and podocytes expressed hCD47/hCD55 but not hCD46/hCD55 without hCD47. Furthermore, masking hCD47 by anti-hCD47 antibody on hCD47/hCD55Tg ECs restored phagocytosis. These results are consistent with the hypothesis that CD47 incompatibility plays an important role in promoting macrophage phagocytosis of endogenous cells from the transplanted kidney.
CONCLUSIONS
The similar levels of phagocytosis of porcine cells by baboon and human macrophages suggest that the expression of hCD47Tg on glomerular cells in donor porcine kidneys may prove to be a key strategy for preventing proteinuria following kidney xenotransplantation in a pig-to-human as well as a pig-to-baboon model.

Identifiants

pubmed: 31495971
doi: 10.1111/xen.12549
pmc: PMC7007337
mid: NIHMS1043824
doi:

Substances chimiques

CD47 Antigen 0
CD47 protein, human 0
alpha-Galactosidase EC 3.2.1.22

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e12549

Subventions

Organisme : NIAID NIH HHS
ID : P01 AI045897
Pays : United States

Informations de copyright

© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Références

Curr Opin Organ Transplant. 2016 Oct;21(5):461-6
pubmed: 27517504
Am J Transplant. 2009 Dec;9(12):2669-78
pubmed: 19845583
Xenotransplantation. 2017 Mar;24(2):
pubmed: 28303661
Transpl Int. 2018 Oct;31(10):1164-1177
pubmed: 29722117
Nephrol Dial Transplant. 2004 Feb;19(2):301-5
pubmed: 14736950
J Am Soc Nephrol. 2014 Apr;25(4):737-44
pubmed: 24459229
J Leukoc Biol. 1991 May;49(5):483-8
pubmed: 2016569
Transplantation. 2017 Feb;101(2):316-321
pubmed: 27232934
Xenotransplantation. 2017 May;24(3):
pubmed: 28393401
Nat Med. 2005 Jan;11(1):32-4
pubmed: 15619627
Xenotransplantation. 2010 Jul-Aug;17(4):267-73
pubmed: 20723199
J Leukoc Biol. 2009 May;85(5):766-78
pubmed: 19181863
Transplantation. 1976 Dec;22(6):559-67
pubmed: 137560
Proc Natl Acad Sci U S A. 2004 May 11;101(19):7335-40
pubmed: 15123792
Blood. 2007 Jan 15;109(2):836-42
pubmed: 17008545
Xenotransplantation. 2018 Sep;25(5):e12391
pubmed: 29527745
Science. 2000 Jun 16;288(5473):2051-4
pubmed: 10856220
Am J Transplant. 2007 Dec;7(12):2775-81
pubmed: 17949457
Transplantation. 2002 Apr 27;73(8):1345-8
pubmed: 11981434
ISRN Hematol. 2013;2013:614619
pubmed: 23401787
Transplantation. 1984 Dec;38(6):607-12
pubmed: 6390821
J Immunol. 1987 Dec 1;139(11):3703-9
pubmed: 2824612
Xenotransplantation. 2016 Sep;23(5):338-46
pubmed: 27610605
Proc Natl Acad Sci U S A. 2007 Mar 20;104(12):5062-6
pubmed: 17360380
Nature. 2018 Dec;564(7736):430-433
pubmed: 30518863

Auteurs

Shunichiro Nomura (S)

Columbia Center for Translational Immunology (CCTI)/Surgery, Columbia University Medical Center, New York, NY, USA.

Yuichi Ariyoshi (Y)

Columbia Center for Translational Immunology (CCTI)/Surgery, Columbia University Medical Center, New York, NY, USA.

Hironosuke Watanabe (H)

Columbia Center for Translational Immunology (CCTI)/Surgery, Columbia University Medical Center, New York, NY, USA.

Thomas Pomposelli (T)

Columbia Center for Translational Immunology (CCTI)/Surgery, Columbia University Medical Center, New York, NY, USA.

Kazuhiro Takeuchi (K)

Columbia Center for Translational Immunology (CCTI)/Surgery, Columbia University Medical Center, New York, NY, USA.

Gabriela Garcia (G)

Department of Medicine, University of Colorado Hospital- Renal Clinic/Nephrology, Aurora, CO, USA.

Masayuki Tasaki (M)

Department of Urology, Graduate School of Medicine, Niigata University, Niigata, Japan.

David Ayares (D)

Revivicor Inc, Blacksburg, VA, USA.

Megan Sykes (M)

Columbia Center for Translational Immunology (CCTI)/Surgery, Columbia University Medical Center, New York, NY, USA.

David Sachs (D)

Columbia Center for Translational Immunology (CCTI)/Surgery, Columbia University Medical Center, New York, NY, USA.

Richard Johnson (R)

Department of Medicine, University of Colorado Hospital- Renal Clinic/Nephrology, Aurora, CO, USA.

Kazuhiko Yamada (K)

Columbia Center for Translational Immunology (CCTI)/Surgery, Columbia University Medical Center, New York, NY, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH